Pioglitazone in addition to metformin improves erythrocyte deformability in patients with type 2 diabetes mellitus. Results from the PIOfix study

被引：0
|
作者：
Forst, S. [1 ]
Loebig, M. [1 ]
Lehmann, U. [2 ]
Hohberg, C. [1 ]
Friedrich, C. [1 ]
Fuchs, W. [2 ]
Pfuetzner, A. [1 ]
Forst, T. [1 ]
机构：
[1] Inst Clin Res & Dev, Mainz, Germany
[2] Takeda Pharma, Dept Med, Aachen, Germany
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1265
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Pioglitazone in addition to metformin improves erythrocyte deformability in patients with Type 2 diabetes mellitus
    Forst, Thomas
    Weber, Matthias M.
    Loebig, Mirjam
    Lehmann, Ute
    Mueller, Juergen
    Hohberg, Cloth
    Friedrich, Christiane
    Fuchs, Winfried
    Pfuetzner, Andreas
    CLINICAL SCIENCE, 2010, 119 (7-8) : 345 - 351
  • [2] Vildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus - results from an exploratory study
    Berndt-Zipfel, Christine
    Michelson, Georg
    Dworak, Markus
    Mitry, Michael
    Loeffler, Andrea
    Pfuetzner, Andreas
    Forst, Thomas
    CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [3] Vildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus – results from an exploratory study
    Christine Berndt-Zipfel
    Georg Michelson
    Markus Dworak
    Michael Mitry
    Andrea Löffler
    Andreas Pfützner
    Thomas Forst
    Cardiovascular Diabetology, 12
  • [4] Tolerability of pioglitazone compared to metformin in patients with Type 2 diabetes mellitus.
    Herz, M
    Tan, MH
    Pavo, I
    Melnichenko, GA
    Shoustov, SB
    Gyimesi, A
    Varkonyi, T
    Johns, D
    Schluchter, BJ
    Widel, M
    DIABETOLOGIA, 2002, 45 : A251 - A252
  • [5] Impact of a Fixed Combination of Pioglitazone with Metformin on Cholesterol Subfractions in Patients with Type 2 Diabetes in Comparison to Metformin plus glimepiride. Results from the Piofix-Study
    Forst, Senait
    Schoendorf, Thomas
    Harzer, Oliver
    Hohberg, Cloth
    Mueller, Juergen
    Kleine, Iris
    Fuchs, Winfried
    Forst, Thomas
    Pfuetzner, Andreas
    DIABETES, 2010, 59 : A576 - A576
  • [6] Pioglitazone enhances insulin sensitivity in patients with Type 2 diabetes mellitus.
    Pavo, I
    Herz, M
    Tan, M
    Shestakova, MV
    Smirnova, OM
    Jermendy, G
    Kerenyi, Z
    Widel, MH
    Schluchter, BJ
    Johns, D
    DIABETOLOGIA, 2002, 45 : A250 - A250
  • [7] Addition of alogliptin vs uptitration of pioglitazone dose in type 2 diabetes mellitus patients on metformin plus pioglitazone therapy
    Bosi, E.
    Ellis, G.
    Moneuse, P.
    Wilson, C.
    Fleck, P.
    DIABETOLOGIA, 2010, 53
  • [8] Vildagliptin in Addition to Metformin Improves Retinal Arteriolar Wall to Lumen Ratio and Erythrocyte Flexibility in Patients With Type 2 Diabetes Mellitus
    Berndt-Zipfel, Christine
    Michelson, Georg
    Klamp, Inga
    Mitry, Michael
    Pfuetzner, Andreas
    Forst, Thomas
    DIABETES, 2013, 62 : A156 - A157
  • [9] Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin
    Ohira, Masahiro
    Yamaguchi, Takashi
    Saiki, Atsuhito
    Ban, Noriko
    Kawana, Hidetoshi
    Nagumo, Ayako
    Murano, Takeyoshi
    Shirai, Kohji
    Tatsuno, Ichiro
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 : 313 - 319
  • [10] Effect of addition of either sitagliptin or pioglitazone in patients with uncontrolled type 2 diabetes mellitus on metformin: A randomized controlled trial
    Chawla, Shalini
    Kaushik, Nitin
    Singh, Narinder Pal
    Ghosh, Raktim Kumar
    Saxena, Alpana
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2013, 4 (01) : 27 - 32
12345